With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies||Emory University / Christopher Porter, MD, Curtis Henry, MD & Christopher Flowers, MD||Innovation Grants||2019||Georgia|
|Targeting Metabolic Vulnerabilities in ETP-ALL||Columbia University / Adolfo A. Ferrando, MD/PhD||Innovation Grants||2017||New York|
|Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma||University of Pennsylvania / Nicole Anderson, PhD||Young Investigator Grants||2016||Pennsylvania|
|Targeting Metabolism in Alveolar Soft Part Sarcomagenesis||Huntsman Cancer Institute / Kevin Jones, MD||'A' Award Grants||2013||Utah|
|Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia||St. Jude Children's Research Hospital / Charles Mullighan, MD/PhD, Hiroki Yoshihara, MD/PhD & Chunxu Qu, PhD||Innovation Grants||2019||Tennessee|
|Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia||University of Rochester / Craig Mullen, MD/PhD||Innovation Grants||2016||New York|
|Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer||Dana-Farber Cancer Institute / Rani George, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|Targeting MYCN||Children's Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD||Crazy 8 Initiative||2019||Pennsylvania|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink||Innovation Grants||2010||New York|